ArticleCancer management and research2021

Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.

Andrew Schaefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.